These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30739038)

  • 1. Administration of tetrahydrobiopterin restored the decline of dopamine in the striatum induced by an acute action of MPTP.
    Kurosaki H; Yamaguchi K; Man-Yoshi K; Muramatsu SI; Hara S; Ichinose H
    Neurochem Int; 2019 May; 125():16-24. PubMed ID: 30739038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
    Sampath C; Kalpana R; Ansah T; Charlton C; Hale A; Channon KM; Srinivasan S; Gangula PR
    Dig Dis Sci; 2019 Dec; 64(12):3502-3517. PubMed ID: 31187328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
    Zhang J; Graham DG; Montine TJ; Ho YS
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of striatal dopaminergic fibers after intraventricular injection of tetrahydrobiopterin in rat brain.
    Kim ST; Chang JW; Hong HN; Hwang O
    Neurosci Lett; 2004 Apr; 359(1-2):69-72. PubMed ID: 15050714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
    Alam G; Edler M; Burchfield S; Richardson JR
    Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Kozina EA; Kim AR; Kurina AY; Ugrumov MV
    Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
    Jung HW; Son HY; Jin GZ; Park YK
    Cell Biochem Funct; 2010 Apr; 28(3):217-23. PubMed ID: 20186864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
    German DC; Nelson EL; Liang CL; Speciale SG; Sinton CM; Sonsalla PK
    Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: a comparison of young and older mice.
    Nishi K; Kondo T; Narabayashi H
    Brain Res; 1989 Jun; 489(1):157-62. PubMed ID: 2568151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-releasing action of 6R-L-erythro-tetrahydrobiopterin: analysis of its action site using sepiapterin.
    Koshimura K; Miwa S; Watanabe Y
    J Neurochem; 1994 Aug; 63(2):649-54. PubMed ID: 7518501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32β transgenic mice.
    Jung YY; Katila N; Neupane S; Shadfar S; Ojha U; Bhurtel S; Srivastav S; Son DJ; Park PH; Yoon DY; Hong JT; Choi DY
    Neurochem Int; 2017 Jan; 102():79-88. PubMed ID: 27956238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo.
    Zhang HN; An CN; Zhang HN; Pu XP
    Neurosci Lett; 2010 Apr; 474(2):99-103. PubMed ID: 20227465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
    J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system.
    Kim ST; Choi JH; Chang JW; Kim SW; Hwang O
    J Neurochem; 2005 Oct; 95(1):89-98. PubMed ID: 16181415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Li S; Pu XP
    Biol Pharm Bull; 2011; 34(8):1291-6. PubMed ID: 21804220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a dopamine-releasing action of 6R-L-erythro-tetrahydrobiopterin: comparison with a 6S-form.
    Koshimura K; Takagi Y; Miwa S; Kido T; Watanabe Y; Murakami Y; Kato Y; Masaki T
    J Neurochem; 1995 Aug; 65(2):827-30. PubMed ID: 7616241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.